Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

VYNE Therapeutics (VYNE) Asset Utilization Ratio (2018 - 2025)

VYNE Therapeutics' Asset Utilization Ratio history spans 8 years, with the latest figure at 0.01 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 45.81% year-over-year to 0.01; the TTM value through Dec 2025 reached 0.01, up 45.81%, while the annual FY2025 figure was 0.01, 93.31% up from the prior year.
  • Asset Utilization Ratio reached 0.01 in Q4 2025 per VYNE's latest filing, up from 0.01 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.16 in Q1 2021 to a low of 0.0 in Q1 2024.
  • Average Asset Utilization Ratio over 5 years is 0.02, with a median of 0.01 recorded in 2022.
  • The largest YoY upside for Asset Utilization Ratio was 927.86% in 2021 against a maximum downside of 93.98% in 2021.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.01 in 2021, then fell by 9.11% to 0.01 in 2022, then tumbled by 43.63% to 0.01 in 2023, then rose by 9.11% to 0.01 in 2024, then soared by 45.81% to 0.01 in 2025.
  • Per Business Quant, the three most recent readings for VYNE's Asset Utilization Ratio are 0.01 (Q4 2025), 0.01 (Q2 2025), and 0.01 (Q1 2025).